The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.
The U.S. Foodand DrugAdministration late Thursday approved ... treatment in decades,” Tiffany Farchione, director of FDA’s division of psychiatry, said in a statement.
Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Some results have been hidden because they may be inaccessible to you